MedTrace Logo

Validation of Saliva in the Esoterix Genetic Laboratories Fragile X Assay

NCT01616589 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2012-06-12

No results posted yet for this study

Summary

The purpose of this research is to determine if saliva samples can be used as an alternate sample type to test for fragile X. By using saliva instead of blood, it would be easier for patients to have fragile X testing.

Conditions

  • Fragile X Syndrome

Sponsors & Collaborators

  • Esoterix Genetic Laboratories, LLC

    lead INDUSTRY

Principal Investigators

  • Thomas Scholl, PhD · Esoterix Genetic Laboratories, LLC

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-07-31
Primary Completion
2012-12-31
Completion
2012-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01616589 on ClinicalTrials.gov